Curaleaf Holdings (CURLF) EBT (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly EBT of -$28.6 million in Q1 2026, up 99.88% quarter-over-quarter from -$24.1 billion in Q4 2025, and down 74.57% on a YoY basis from -$112.6 million in Q1 2025.
Curaleaf Holdings (CURLF) EBT (2019 - 2026) Analysis & Trends
Curaleaf Holdings' EBT history runs 8 years deep, the most recent figure standing at -$28.6 million for Q1 2026.
- In Q1 2026, EBT fell 74.57% year-over-year to -$28.6 million; the TTM figure through Mar 2026 stood at -$43.4 billion (down 36585.1% YoY), while the FY2025 annual figure was -$78.2 million, up 31.0% from the prior year.
- EBT was -$28.6 million for Q1 2026 at Curaleaf Holdings, up from -$24.1 billion in the prior quarter.
- In the past five years, EBT ranged from a high of $31.9 million in Q2 2022 to a low of -$60.6 billion in Q4 2023.
- Historically, EBT has averaged -$6.1 billion across 5 years, with a median of -$24.3 million in 2025.
- The sharpest annual moves came in 2022 and 2025: EBT surged 223.7% in 2022, then plunged 111897.44% in 2025.
- A 5-year view of EBT shows it stood at -$249.2 million in 2022, then plunged by 24226.2% to -$60.6 billion in 2023, then soared by 99.88% to -$73.0 million in 2024, then sank by 32967.43% to -$24.1 billion in 2025, then jumped by 99.88% to -$28.6 million in 2026.
- The last three EBT figures came in at -$28.6 million (Q1 2026), -$24.1 billion (Q4 2025), and -$24.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 437.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 758.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 318.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 17.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 246.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 87.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -61.93 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 156.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -101.55 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -28.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.63 Mn |
| Dec 31, 2025 | -24.13 Bn |
| Sep 30, 2025 | -24.31 Mn |
| Jun 30, 2025 | -19.22 Bn |
| Mar 31, 2025 | -16.40 Mn |
| Dec 31, 2024 | -72.96 Mn |
| Sep 30, 2024 | -11.78 Mn |
| Jun 30, 2024 | -17.16 Mn |
| Mar 31, 2024 | -11.49 Mn |
| Dec 31, 2023 | -60.63 Bn |
| Sep 30, 2023 | -35.95 Mn |
| Jun 30, 2023 | -24.64 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -249.22 Mn |
| Sep 30, 2022 | 8.55 Mn |
| Jun 30, 2022 | 31.90 Mn |
| Mar 31, 2022 | 21.39 Mn |
| Dec 31, 2021 | -40.37 Mn |
| Sep 30, 2021 | 2.64 Mn |
| Jun 30, 2021 | 34.34 Mn |